Cite
HARVARD Citation
Tsuchiya, S. et al. (2017). Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once‐weekly dipeptidyl peptidase‐4 inhibitor, in healthy Japanese men. Journal of diabetes investigation. 8 (1), pp. 84-92. [Online].